# Misty Dawn Shields

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/misty-dawn-shields/

## Facts

| Field | Value |
| --- | --- |
| Citations | 760 |
| Field | Lung Cancer Research Studies |
| h-index | 12 |
| i10-index | 13 |
| Last Known Institution | Indiana University Health |
| OpenAlex ID | https://openalex.org/A5010134367 |
| ORCID iD | 0000-0002-7904-5062 |
| Works | 70 |

## Researcher papers

- [Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells](https://scholariq.org/papers/metabolic-diversity-in-human-non-small-cell-lung-cancer-cells-2/)
- [Immunotherapy for Advanced Non–Small Cell Lung Cancer: A Decade of Progress](https://scholariq.org/papers/immunotherapy-for-advanced-non-small-cell-lung-cancer-a-decade-of-progress/)
- [NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM](https://scholariq.org/papers/neurod1-regulates-survival-and-migration-of-neuroendocrine-lung-carcinomas-via/)
- [Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors](https://scholariq.org/papers/commercial-ctdna-assays-for-minimal-residual-disease-detection-of-solid-tumors/)
- [Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer](https://scholariq.org/papers/making-the-rounds-exploring-the-role-of-circulating-tumor-dna-ctdna-in-non-small/)
- [Differential association of β2-microglobulin mutants with MHC class I heavy chains and structural analysis demonstrate allele-specific interactions](https://scholariq.org/papers/differential-association-of-2-microglobulin-mutants-with-mhc-class-i-heavy/)
- [A systematic review and meta-analysis of selected toxicity endpoints of alpelisib](https://scholariq.org/papers/a-systematic-review-and-meta-analysis-of-selected-toxicity-endpoints-of/)
- [Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity](https://scholariq.org/papers/molecular-landscape-and-therapeutic-strategies-of-lung-cancer-lineage-plasticity/)
- [Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells](https://scholariq.org/papers/metabolic-diversity-in-human-non-small-cell-lung-cancer-cells/)
- [Top advances of the year: Small cell lung cancer](https://scholariq.org/papers/top-advances-of-the-year-small-cell-lung-cancer/)
- [SEZ6 expression and lineage plasticity in small cell lung cancer and transformed non-small cell lung cancer](https://scholariq.org/papers/sez6-expression-and-lineage-plasticity-in-small-cell-lung-cancer-and-transformed/)

## Researcher topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Researcher university

- [Indiana University Health](https://scholariq.org/institutions/indiana-university-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.